Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group-Reference-Cited by-同舟云学术

Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group

Published:2010-11 Issue:11 Volume:45 Page:2160-2168
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Raney Beverly,Stoner Julie,Anderson James,Andrassy Richard,Arndt Carola,Brown Ken,Crist William,Maurer Harold,Qualman Stephen,Wharam Moody,Wiener Eugene,Meyer William,Hayes-Jordan Andrea

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology, and Child Health,Surgery

Reference17 articles.

1. The Intergroup Rhabdomyosarcoma Study-I: A final report;Maurer;Cancer,1988

2. The Intergroup Rhabdomyosarcoma Study-II;Maurer;Cancer,1993

3. The Third Intergroup Rhabdomyosarcoma Study;Crist;J Clin Oncol,1995

4. Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease;Crist;J Clin Oncol,2001

5. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG;Donaldson;Int J Radiat Oncol Biol Phys,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies;Frontiers in Oncology;2021-09-16

2. Radiation therapy for infants with cancer;Pediatric Blood & Cancer;2021-04-05

3. Relationship between tumor viability during treatment and the clinical outcomes of patients with bladder/prostate rhabdomyosarcoma: a single-center experience;The Turkish Journal of Pediatrics;2021

4. Rhabdomyosarcoma;Pediatric Surgery;2021

5. Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group;International Journal of Cancer;2020-02-15